Related Experiment Videos
[Results of treatment for severe acquired aplastic anemia in children]
M Ochocka1, M Karwacki, M Matysiak
1Klinika Hematologii i Chorób Rozrostowych Dzieci Akademii Medycznej w Warszawie.
Insights
Treatments for acquired aplastic anemia in children show varying survival rates. Antilymphocyte globulin (ALG) and cyclosporin A (CsA) offer similar 5-year survival, outperforming oxymetholone and prednisolone.
Area of Science:
- Pediatric Hematology
- Immunosuppressive Therapy
- Bone Marrow Failure Syndromes
Context:
- Acquired aplastic anemia (AAA) is a rare but serious bone marrow failure syndrome in children.
- Treatment outcomes for pediatric AAA vary significantly based on disease severity and therapeutic approach.
- Understanding survival rates and treatment efficacy is crucial for managing this condition.
Purpose:
- To evaluate the treatment outcomes and survival rates of 106 children diagnosed with acquired aplastic anemia.
- To compare the efficacy of different therapeutic regimens, including oxymetholone and prednisolone, antilymphocyte globulin (ALG), and cyclosporin A (CsA).
- To explore potential correlations between AAA incidence and environmental factors, such as the Chernobyl disaster.
Summary:
- The study analyzed 106 pediatric AAA cases, stratified by severity (very severe, severe, non-severe).
- Patients treated with oxymetholone and prednisolone had high mortality (32 deaths).
- Antilymphocyte globulin (ALG) and cyclosporin A (CsA) demonstrated comparable 5-year survival rates (61% and 59%, respectively).
- One patient undergoing bone marrow transplantation achieved complete remission.
- A potential increase in AAA incidence from 1987-1989 was noted, possibly linked to the Chernobyl explosion, requiring further investigation.
Impact:
- This research provides critical data on the comparative effectiveness of different treatments for pediatric acquired aplastic anemia.
- Findings highlight ALG and CsA as more favorable therapeutic options compared to older regimens.
- The study underscores the need for continued research into the etiology and optimal management of pediatric AAA.
Abstract:
The authors evaluated results of treatment of 106 children with acquired aplastic anemia. The patients were divided into 3 groups depending on the severity of their disease. Thirty-nine patients were classified as very severe, 30 as severe and 37 as non-severe according to the modified Camitta criteria. Among them, 47 children were treated with oxymetholone and prednisolone. In this group 32 died. Antilymphocyte globulin (ALG) was given to 48 patients and 20 received cyclosporin A (CsA). The results obtained by these two methods are nearly the same and 5 year survival was 61% and 59% respectively. Bone marrow was transplanted in only one child, who is still in complete remission. Statistical analysis showed a steady increase in incidence of aplastic anemia in the years 1987-1989, which might coincide with the Czarnobyl explosion. However, further research is required to prove this point.